Immunomedics Inc – ‘424B3’ on 12/1/98

As of:  Tuesday, 12/1/98   ·   Accession #:  722830-98-12   ·   File #:  33-56844

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Prospectus   —   Rule 424(b)(3)
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 424B3       Prospectus                                             2     10K 

Document Table of Contents

424B3
1st Page of 2
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 

================================================================================

               Filed pursuant to Rule 424(b)(3) under the Securities Act of 1933
                               Registration Statement on Form S-8 (No. 33-56844)

PROSPECTUS SUPPLEMENT 
(to the Prospectus, dated January 7, 1993)

IMMUNOMEDICS, INC.

3,000,000 Shares

Common Stock, $.01 Par Value

This  Prospectus  Supplement  constitutes an essential  part of the  Prospectus,
dated January 7, 1993, of  Immunomedics,  Inc. and should be read in conjunction
with such Prospectus.                                                           

The  information  set forth below  supersedes the  information  contained  under
"Selling Stockholders" in the Prospectus. All capitalized terms used herein have
the meanings given such terms in the Prospectus.                                

SELLING STOCKHOLDERS                                                            

     The  shares of Common  Stock to which  this  Prospectus  relates  are being
registered for reoffers and resales by Selling  Stockholders  of the Company who
may acquire  such shares  pursuant to the  exercise of options  granted or to be
granted under the Plan. The Selling  Stockholders  named below may resell all, a
portion,  or none of the shares that they acquire or may acquire pursuant to the
exercise of options under the Plan.                                             

     Participants  under  the  Plan who are  deemed  to be  "affiliates"  of the
Company  who  acquire  Common  Stock  under the Plan may be added to the Selling
Stockholders listed below from time to time, either by means of a post-effective
amendment to the  Registration  Statement  or by use of a prospectus  supplement
filed  pursuant to Rule 424(c) under the 1933 Act. An  "affiliate" is defined in
Rule 405 under the 1933 Act as a "person that directly,  or indirectly,  through
one or more  intermediaries,  controls,  or is controlled by, or is under common
control with", the Company.                                                     

     The following table sets forth certain  information  concerning the Selling
Stockholders  as of the date of this  Prospectus.  Except  as  disclosed  in the
table,  none of the Selling  Stockholders  listed  below has, or within the past
three years has had, any position,  office or other material  relationship  with
the Company or any of its predecessors or affiliates.                           

424B3
Last Page of 2
TOC
1st
Previous
Next
↓Bottom
Just 2nd
                                                                [Download Table]

                                                              Maximum Number of 
                                                              Shares Subject to 
                                                             Outstanding Options
                               Position With                     Which May Be   
Name                            The Company                   Reoffered Hereby 1
________________________________________________________________________________

                                                                                
David M. Goldenberg            Chairman of the Board,                    525,000
                               Chief Executive Officer                          
                               and Director                                     

Robert J. DeLuccia             President, Chief Executive                200,000
                               Officer and Director                             

W. Robert Friedman, Jr.        Director                                   20,000

Marvin E. Jaffe                Director                                   50,000

Richard R. Pivirotto           Director                                   60,000

Richard C. Williams            Director                                   60,000

Hans J. Hansen                 Vice President -                          245,000
                               Research and Development                         

Kevin F.X. Brophy              Vice President -                           28,000
                               Finance & Administration                         

Joseph E. Presslitz            Vice President -                          158,500
                               Regulatory Affairs                               

________________________________________________________________________________


1.      As of December 1, 1998. does not constitute a commitment to sell any or 
all of the stated number of shares of Common Stock. The number of shares offered
shall be determined  from time to time by each Selling  Stockholder  at his sole
discretion.                                                                     

The date of this Prospectus Supplement is December 1, 1998. 

Dates Referenced Herein

				Referenced-On Page
This ‘424B3’ Filing		Date		First		Last			Other Filings
Filed on:		12/1/98		2					None on these Dates
		1/7/93		1
									List all Filings